The table below shows ANAPTYSBIO, INC's cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q1 2025
Q1 2024
Q1 2023
Q1 2022
Q1 2021
Operating cash flow
-$25.92M
-$10.70M
-$37.25M
-$24.57M
-$21.01M
-$23.20M
Capital expenditure
$17.00K
$35.00K
$27.00K
$175.00K
$55.00K
$317.00K
Investing cash flow
$34.98M
$14.85M
$68.62M
$85.40M
-$312.91M
$56.73M
Dividends paid
-
-
-
-
ANAB operating cash flow (10-K history)
ANAPTYSBIO, INC reported operating cash flow of $19.70M for fiscal year 2025. That is up 114.6% from -$135.34M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow grew from -$9.03M (FY 2016) to $19.70M. Figures come from the company's audited annual reports as filed with the SEC.